LogicBio Therapeutics, Inc. Diluted Shares Outstanding (Weighted Average)
LogicBio Therapeutics, Inc. reported Diluted Shares Outstanding (Weighted Average) of 32.96 million shares for the 3-month period ending 2022-09-30, per its 10-Q filed 2022-11-14.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2022-11-14
- LogicBio Therapeutics, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2022-09-30 was 32.96M shares, a 1.60% increase year-over-year.
- LogicBio Therapeutics, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2022-06-30 was 32.96M shares, a 2.49% increase year-over-year.
- LogicBio Therapeutics, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2021-09-30 was 32.44M shares.
- LogicBio Therapeutics, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2021-06-30 was 32.16M shares.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 9 month |
|---|---|---|---|
| 2022-09-30 | 32.96M shares 10-Q · filed 2022-11-14 | 32.96M shares derived: average of 2 quarters · filed 2022-11-14 | 32.96M shares 10-Q · filed 2022-11-14 |
| 2022-06-30 | 32.96M shares 10-Q · filed 2022-08-15 | 32.96M shares 10-Q · filed 2022-08-15 | |
| 2021-09-30 | 32.44M shares 10-Q · filed 2022-11-14 | 32.30M shares derived: average of 2 quarters · filed 2022-11-14 | 32.18M shares 10-Q · filed 2022-11-14 |
| 2021-06-30 | 32.16M shares 10-Q · filed 2022-08-15 | 32.05M shares 10-Q · filed 2022-08-15 |